Exicure Inc is a biotechnology company that develops nucleic acid therapies targeting ribonucleic acid against validated targets for neurological disorders and hair loss. It operates in a single segment, which is the discovery, research, and development of treatments based on its SNA (Spherical Nucleic Acid) technology.

Address

2430 N. Halsted Street

Suite 410

Website

https://www.exicuretx.com

Classification

Sector

Healthcare

Industry Group

Biotechnology

Industry

Biotechnology

Key Executives

Ms. Jiyoung Hwang

CFO/Director/Secretary

Mr. Paul Kang

CEO/Director/President

Mr. Joshua Miller

Chief Accounting Officer

Mr. Hyuk Joon Ko

Director

Mr. Dongho Lee

Director

Mr. Hojoon Lee

Director

Ms. Minhee Eom

Director

Ownership

Institution Holdings

The Carlyle Group Inc

281,636 (3.257%)

Armistice Capital, LLC

260,746 (3.015%)

Carlson Capital LP.

250,000 (2.891%)

Millennium Management LLC

57,815 (0.669%)

Geode Capital Management, LLC

52,996 (0.613%)

Fidelity Management & Research Company LLC

52,439 (0.606%)

Northwestern University

52,145 (0.603%)

Renaissance Technologies Corp

49,500 (0.572%)

Vanguard Group Inc

40,093 (0.464%)

Citadel Advisors Llc

20,883 (0.241%)

Funds Holdings

BlackRock Extended Equity Market

4,305 (0.050%)

NT Ext Equity Mkt Idx Fd - DC - NL

1,784 (0.021%)

Extended Equity Market Fund M

532 (0.006%)

SSgA U.S. Total Market Index Fund

282 (0.003%)

BNYM Mellon SL Market Completion Fund

143 (0.002%)

Details

Overview

Company Info

Key Ratios

Income

Balance Sheet

Cash Flow

Bubble

Make Smart Investment Choices